2021
DOI: 10.1093/ofid/ofab629
|View full text |Cite
|
Sign up to set email alerts
|

A Novel Program to Provide Drug Recovery Assistance and Outpatient Parenteral Antibiotic Therapy in People Who Inject Drugs

Abstract: Background Safe hospital discharge on parenteral antibiotic therapy is challenging for people who inject drugs (PWID) admitted with serious bacterial infections (SBI). We describe a Comprehensive Care of Drug Addiction and Infection (CCDAI) program involving a partnership between Intermountain Healthcare hospitals and a detoxification facility (DF) to provide simultaneous drug recovery assistance and parenteral antibiotic therapy (DRA-OPAT). M… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

0
2
0

Year Published

2022
2022
2024
2024

Publication Types

Select...
5

Relationship

0
5

Authors

Journals

citations
Cited by 5 publications
(2 citation statements)
references
References 19 publications
0
2
0
Order By: Relevance
“…Management of serious bacterial infections in people who inject drugs (PWID) is complicated by concerns with utilizing OPAT. Gelman and colleagues describe a novel approach to managing drug recovery assistance and outpatient parenteral antibiotic therapy (DRA-OPAT) for PWID [ 34 ]. They established a multidisciplinary Comprehensive Care of Drug Addiction and Infection (CCDAI) team including an ID physician, hospitalist, psychiatrist, case manager, ID pharmacist, home health care nurse, and a representative from the partner detoxification facility.…”
Section: Resultsmentioning
confidence: 99%
“…Management of serious bacterial infections in people who inject drugs (PWID) is complicated by concerns with utilizing OPAT. Gelman and colleagues describe a novel approach to managing drug recovery assistance and outpatient parenteral antibiotic therapy (DRA-OPAT) for PWID [ 34 ]. They established a multidisciplinary Comprehensive Care of Drug Addiction and Infection (CCDAI) team including an ID physician, hospitalist, psychiatrist, case manager, ID pharmacist, home health care nurse, and a representative from the partner detoxification facility.…”
Section: Resultsmentioning
confidence: 99%
“… 20 , 21 One program reported significantly lower antibiotic completement rates for PWID with infective endocarditis treated at a SUD treatment facility (46%) compared to a historical control group treated in the hospital (74%), although with similar readmission and mortality outcomes. 22 Improving prescription of MOUD during hospitalizations for severe infections may reduce early patient-directed discharge 23 and post-discharge mortality, 24 although many studies have reported difficulty improving the rate of MOUD use even with dedicated programs. 25 , 26 …”
Section: Discussionmentioning
confidence: 99%